101 – 141 of 141
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- 3
- next »
- 2010
-
Mark
The diagnostic performance of APC-PCI complex determination compared to d-dimer in the diagnosis of deep vein thrombosis
(
- Contribution to journal › Article
-
Mark
The effect of low molecular weight heparin (dalteparin) on duration and initiation of labour.
(
- Contribution to journal › Article
-
Mark
Upper extremity deep venous thrombosis in the population-based Malmö thrombophilia study (MATS). Epidemiology, risk factors, recurrence risk, and mortality.
(
- Contribution to journal › Article
-
Mark
A Cost-effectiveness Analysis of Diagnostic Algorithms of Deep Vein Thrombosis at the Emergency Department.
(
- Contribution to journal › Article
-
Mark
Von Willebrands sjukdom--från biokemi till klinisk praxis.
(
- Contribution to journal › Scientific review
- 2009
-
Mark
Prospective analysis of risk factors and distribution of venous thromboembolism in the population-based Malmö Thrombophilia Study (MATS).
(
- Contribution to journal › Article
-
Mark
Comparison and evaluation of a Point-of-care device (CoaguChek XS) to Owren-type prothrombin time assay for monitoring of oral anticoagulant therapy with warfarin.
(
- Contribution to journal › Article
-
Mark
Three-Year Survival and Stroke Recurrence Rates in Patients With Primary Intracerebral Hemorrhage.
(
- Contribution to journal › Article
-
Mark
Performance of two relatively new quantitative D-dimer assays (Innovance D-dimer and AxSYM D-dimer) for the exclusion of deep vein thrombosis.
(
- Contribution to journal › Article
-
Mark
Trombocytopeni kan vara HIT. Heparinbehandling kan ge livshotande låga trombocytvärden
(
- Contribution to journal › Article
- 2008
-
Mark
Efficacy and safety of anticoagulant prophylaxis to prevent venous thromboembolism in acutely ill medical inpatients: a meta-analysis
(
- Contribution to journal › Article
-
Mark
Epidemiology, risk and prognostic factors in mesenteric venous thrombosis.
(
- Contribution to journal › Article
-
Mark
The Factor V Leiden mutation is associated with a higher blood haemoglobin concentration in women below 50 of the Malmö Thrombophilia Study (MATS).
(
- Contribution to journal › Article
-
Mark
Blödningstidsbestämning har spelat ut sin roll. Otillförlitlig metod som inte längre bör användas i rutinsjukvården
(
- Contribution to journal › Scientific review
- 2007
-
Mark
Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC-PCI complex concentration and/or soluble thrombomodulin antigen and activity.
(
- Contribution to journal › Article
-
Mark
Menorrhagia and minor bleeding symptoms in women on oral anticoagulation.
(
- Contribution to journal › Article
-
Mark
Evidens för trombosprofylax till medicinpatienter med hög risk
(
- Contribution to journal › Article
- 2006
-
Mark
The complex between activated protein C and protein C inhibitor: A clinically useful indicator of aortic aneurysms?
(
- Contribution to journal › Article
- 2005
-
Mark
Factor V Leiden and the prothrombin 20210A gene mutation and osteonecrosis of the knee.
(
- Contribution to journal › Article
-
Mark
APC-PCI complex concentration is higher in patients with previous venous thromboembolism with Factor V Leiden.
(
- Contribution to journal › Letter
-
Mark
Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT)
(
- Contribution to journal › Article
-
Mark
Recurrence Rate After a First Venous Thrombosis in Patients With Familial Thrombophilia.
(
- Contribution to journal › Article
- 2004
-
Mark
Comparison between CoaguChek S- and Owren-type prothrombin time assay for monitoring anticoagulant therapy.
(
- Contribution to journal › Article
-
Mark
Hereditary thrombophilia and fetal loss: a prospective follow-up study
(
- Contribution to journal › Article
-
Mark
Familial thrombophilia and lifetime risk of venous thrombosis
(
- Contribution to journal › Article
-
Mark
Factor V leiden and prothrombin gene mutation: risk factors for osteonecrosis of the femoral head in adults.
(
- Contribution to journal › Article
- 2003
-
Mark
Risk of haemorrhagic stroke in patients with oral anticoagulation compared with the general population
(
- Contribution to journal › Article
- 2002
-
Mark
Multidisciplinär kurs i akutmedicin ger ST-läkare större säkerhet
(
- Contribution to journal › Article
- 2000
-
Mark
Inflammatory bowel disease promotes venous thrombosis earlier in life
(
- Contribution to journal › Article
- 1999
-
Mark
Nytt system testar den mekaniska hjärtklaffen. Egenkontroll i hemmet av antivitamin K-terapin ger patienten större frihet
(
- Contribution to journal › Article
- 1998
-
Mark
The A20210 allele of the prothrombin gene is frequently associated with the factor V Arg 506 to Gln mutation but not with protein S deficiency in thrombophilic families
(
- Contribution to journal › Letter
-
Mark
The A20210 allele of the prothrombin gene is frequently associated with the factor V Arg 506 to Gln mutation but not with protein S deficiency in thrombophilic families [3]
(
- Contribution to journal › Letter
- 1997
-
Mark
Resistance to activated protein C a novel risk factor for venous thrombosis
1997)(
- Thesis › Doctoral thesis (compilation)
-
Mark
The 20210 A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
The factor VR506Q mutation causing APC resistance is highly prevalent amongst unselected outpatients with clinically suspected deep venous thrombosis
(
- Contribution to journal › Article
-
Mark
Evaluation of original and modified APC-resistance tests in unselected outpatients with clinically suspected thrombosis and in healthy controls
(
- Contribution to journal › Article
-
Mark
The factor VR5O6Q mutation causing APC resistance is highly prevalent amongst unselected outpatients with clinically suspected deep venous thrombosis
(
- Contribution to journal › Article
- 1996
-
Mark
Elevated levels of prothrombin activation fragment 1 + 2 in plasma from patients with heterozygous Arg506 to Gln mutation in the factor V gene (APC-resistance) and/or inherited protein S deficiency
(
- Contribution to journal › Article
- 1995
-
Mark
Resistens mot aktiverat protein C. Vanlig genetisk riskfaktor för venös trombos
(
- Contribution to journal › Article
- 1994
-
Mark
Myocardial infarction associated with homozygous resistance to activated protein C
(
- Contribution to journal › Letter
-
Mark
Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C
(
- Contribution to journal › Article
- « previous
- 1
- 2
- 3
- next »